Will CBD Start Being Produced to Factory Precision Like Other Medicines?

February 3, 2020 16:00:13

Cannabidiol (CBD), is undoubtedly one of the break-out drugs of the decade. Even though a lot of the medical claims haven’t been proven yet, and it is extracted from a plant fraught with controversy, CBD is still going strong. More people are turning towards it to help manage their ailments, companies are investing tons of cash in the sector and regulatory authorities are scrambling to regulate the runaway sector.

The hemp extract is part of a group of compounds produced by the cannabis plant called cannabinoids, and these chemicals, with CBD in the lead, have shown great promise as natural medicines. CBD is said to be effective against a plethora of conditions ranging from…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.